keyword
MENU ▼
Read by QxMD icon Read
search

Drug induced immune hemolytic anemia

keyword
https://www.readbyqxmd.com/read/27316915/french-intensive-care-society-international-congress-r%C3%A3-animation-2016
#1
(no author information available yet)
No abstract text is available yet for this article.
June 2016: Annals of Intensive Care
https://www.readbyqxmd.com/read/27304608/unusual-serological-findings-associated-with-ceftriaxone-induced-immune-hemolytic-anemia-in-a-child-with-disseminated-low-grade-glioma
#2
L H Pecker, A Timsar, P P Pary, G A Denomme, V R Criss, N L C Luban, E I Hwang, E C C Wong
Ceftriaxone-induced immune hemolytic anemia (CIHA) is the second most common cause of drug-induced hemolytic anemia. Prompt recognition of this drug reaction is essential because brisk hemolysis can be deadly. The extent to which ceftriaxone antibodies persist after CIHA is unknown; rechallenging patients who have experienced CIHA is not recommended. We report a case of CIHA in a neurooncology patient, which is the first to show anticeftriaxone antibodies with Rh specificity and persisted for 8 months after the drug reaction...
October 2016: Pediatric Blood & Cancer
https://www.readbyqxmd.com/read/27270429/targeting-6-phosphogluconate-dehydrogenase-in-the-oxidative-ppp-sensitizes-leukemia-cells-to-antimalarial-agent-dihydroartemisinin
#3
S Elf, R Lin, S Xia, Y Pan, C Shan, S Wu, S Lonial, M Gaddh, M L Arellano, H J Khoury, F R Khuri, B H Lee, T J Boggon, J Fan, J Chen
The oxidative pentose phosphate pathway (PPP) is crucial for cancer cell metabolism and tumor growth. We recently reported that targeting a key oxidative PPP enzyme, 6-phosphogluconate dehydrogenase (6PGD), using our novel small-molecule 6PGD inhibitors Physcion and its derivative S3, shows anticancer effects. Notably, humans with genetic deficiency of either 6PGD or another oxidative PPP enzyme, glucose-6-phosphate dehydrogenase, exhibit non-immune hemolytic anemia upon exposure to aspirin and various antimalarial drugs...
June 6, 2016: Oncogene
https://www.readbyqxmd.com/read/26859672/drug-induced-immune-hemolytic-anemia-associated-with-albumin-bound-paclitaxel
#4
Roby Thomas, Alexandra Shillingburg
Drug-induced immune hemolytic anemia (DIIHA) is rare, with only 1 patient in 1 million affected by the condition.1 Garratty identified 125 drugs indicated in DIIHA of which 11% were antineoplastic agents, and neither paclitaxel nor albumin-bound paclitaxel were included.2 In addition, we did not find any reports in our own search of the literature. Taxanes are known to cause anemia as a result of their myelosuppressive effects, but an immune hemolysis is rare. To our knowledge, we present here the first case of DIIHA with nab-paclitaxel...
August 2015: Journal of Community and Supportive Oncology
https://www.readbyqxmd.com/read/26822544/diversity-and-severity-of-adverse-reactions-to-quinine-a-systematic-review
#5
REVIEW
Nathan W Liles, Evaren E Page, Amber L Liles, Sara K Vesely, Gary E Raskob, James N George
Quinine is a common cause of drug-induced thrombocytopenia and the most common cause of drug-induced thrombotic microangiopathy. Other quinine-induced systemic disorders have been described. To understand the complete clinical spectrum of adverse reactions to quinine we searched 11 databases for articles that provided sufficient data to allow evaluation of levels of evidence supporting a causal association with quinine. Three reviewers independently determined the levels of evidence, including both immune-mediated and toxic adverse reactions...
May 2016: American Journal of Hematology
https://www.readbyqxmd.com/read/26306021/-hemolytic-anemias-and-vitamin-b12-deficieny
#6
Hermann Dietzfelbinger, Max Hubmann
Hemolytic anemias consist of corpuscular, immun-hemolytic and toxic hemolytic anemias. Within the group of corpuscular hemolytic anemias, except for the paroxysmal nocturnal hemoglobinuria (PNH), all symptoms are caused by underlying heredetiary disorders within the red blood cell membran (hereditary spherocytosis), deficiencies of red cell enzymes (G6PDH- and pyrovatkinase deficiency) or disorders in the hemoglobin molecule (thalassaemia and sickle cell disease). Immune-hemolytic anemias are acquired hemolytic anemias and hemolysis is caused by auto- or allo-antibodies which are directed against red blood cell antigens...
August 2015: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/26264449/drug-induced-immune-hemolytic-anemia-associated-with-anti-carboplatin-and-the-first-example-of-anti-paclitaxel
#7
Regina M Leger, Shweta Jain, Theresa A Nester, Henry Kaplan
BACKGROUND: Combined chemotherapy with carboplatin and paclitaxel is first-line treatment for lung and ovarian cancer. Drug-induced antibodies to carboplatin are rare but can cause severe, even fatal, hemolysis. Paclitaxel-induced immune hemolysis has not been reported. We describe a case of immune-mediated hemolysis associated with antibodies to carboplatin and paclitaxel in a woman with ovarian cancer who had received multiple chemotherapeutic agents over 7 years, including several courses of these two drugs...
December 2015: Transfusion
https://www.readbyqxmd.com/read/26190328/autoimmune-hemolytic-anemia-in-treatment-naive-chronic-hepatitis-c-infection-a-case-report-and-review-of-literature
#8
Robert J Basseri, Michael T Schmidt, Benjamin Basseri
The hepatitis C virus (HCV) is the most common blood-borne pathogen and currently infects over two hundred and fifty million individuals worldwide. Chronic HCV infection may result in cirrhosis, hepatocellular carcinoma, and liver failure. An exceedingly rare extrahepatic manifestation of HCV is autoimmune hemolytic anemia (AIHA). We discuss an interesting case of direct Coombs'-positive AIHA in a treatment-naive 53-year-old male with a past medical history of HCV cirrhosis, genotype 3a, who presented with fatigue, abdominal pain, and jaundice...
October 2010: Clinical Journal of Gastroenterology
https://www.readbyqxmd.com/read/25986273/intravascular-hemolytic-anemia-in-a-patient-with-antibodies-related-to-meropenem
#9
Satoko Oka, Hiroshi Shiragami, Masaharu Nohgawa
A 76-year-old woman treated with meropenem developed intravascular hemolytic attacks. A direct antiglobulin test was positive for C3d and IgG, and drug-dependent antibody testing indicated that the antibodies were indeed drug-dependent and reacted with drug-treated RBCs and RBCs in the presence of the drug. To our knowledge, this is the first reported case in which the causative antibodies related to meropenem were identified. This case highlights the importance of maintaining a high level of suspicion for drug-induced immune hemolytic anemia in patients with explained hemolysis as well as conducting specialized serologic testing...
2015: Internal Medicine
https://www.readbyqxmd.com/read/25714764/-ceftriaxone-induced-immune-haemolytic-anaemia-and-multi-organ-failure
#10
Chantal E Mulkens, Ellen G van Lochem, Claudia C Folman, Ellen van der Spek, Henk J van Leeuwen
BACKGROUND: Drug-induced immune haemolytic anaemia (DIIHA) is caused by various drugs or their metabolites. Cephalosporins are associated with haemolytic anaemia but multi-organ failure is rarely described. CASE DESCRIPTION: We report the case of a 57-year-old female who was diagnosed with neuroborreliosis and treated with ceftriaxone. The patient developed severe DIIHA. Massive intravascular haemolysis led to shock and acute renal failure, necessitating mechanical ventilation and dialysis...
2015: Nederlands Tijdschrift Voor Geneeskunde
https://www.readbyqxmd.com/read/25473172/ribavirin-induced-hemolysis-a-novel-mechanism-of-action-against-chronic-hepatitis-c-virus-infection
#11
REVIEW
Kaartik Soota, Benedict Maliakkal
Hepatitis C virus (HCV) is not usually cleared by our immune system, leading to the development of chronic hepatitis C infection. Chronic HCV induces the production of various cytokines, predominantly by Kupffer cells (KCs), and creates a pro-inflammatory state in the liver. The chronic dysregulated production of interferon (IFN) and other cytokines by KCs also promotes innate immune tolerance. Ribavirin (RBV) monotherapy has been shown to decrease inflammation in liver of patients with chronic hepatitis C...
November 21, 2014: World Journal of Gastroenterology: WJG
https://www.readbyqxmd.com/read/25352126/inhibition-of-fc%C3%AE-r-mediated-phagocytosis-by-ivig-is-independent-of-igg-fc-sialylation-and-fc%C3%AE-riib-in-human-macrophages
#12
Sietse Q Nagelkerke, Gillian Dekkers, Iwan Kustiawan, Fleur S van de Bovenkamp, Judy Geissler, Rosina Plomp, Manfred Wuhrer, Gestur Vidarsson, Theo Rispens, Timo K van den Berg, Taco W Kuijpers
In immune thrombocytopenia and warm autoimmune hemolytic anemia, circulating immunoglobulin G (IgG)-opsonized blood cells are cleared from the circulation by macrophages. Administration of intravenous immunoglobulin (IVIg) can prevent uptake, but the exact working mechanism is not known. The prevailing theory from murine studies, which states that Fc-sialylated IgG alters the balance between activating and inhibitory Fc-gamma receptors (FcγRs) by inducing upregulation of the inhibitory FcγRIIb on effector macrophages, is currently debated...
December 11, 2014: Blood
https://www.readbyqxmd.com/read/25350999/introduction-to-immunohematology-special-edition-on-drug-induced-immune-cytopenias
#13
EDITORIAL
Patricia A Arndt, Regina M Leger
No abstract text is available yet for this article.
2014: Immunohematology
https://www.readbyqxmd.com/read/25306236/severe-delayed-autoimmune-haemolytic-anaemia-following-artesunate-administration-in-severe-malaria-a-case-report
#14
Loic Raffray, Marie-Catherine Receveur, Mathilde Beguet, Pierre Lauroua, Thierry Pistone, Denis Malvy
BACKGROUND: Parenteral artesunate is recommended as first-line therapy for severe and complicated malaria. Although its efficacy has been proven, long-term safety profile is still under evaluation. Several cases of delayed haemolytic anaemia occurred after initial clinical improvement and resolution of parasitaemia in non-immune travellers and children living in endemic areas. Reports have generated concern that this phenomenon might be related to the treatment itself, either by direct toxicity or immune-related mechanism...
2014: Malaria Journal
https://www.readbyqxmd.com/read/25247622/drug-induced-immune-hemolytic-anemia-the-last-30-years-of-changes
#15
REVIEW
Patricia A Arndt
Drug-induced immune hemolytic anemia (DIIHA) is a rare condition that occurs primarily as a result of drug-induced antibodies, either drug-dependent or drug-independent. Drug- dependent antibodies can be detected by testing drug-treated red blood cells (RBCs) or untreated RBCs in the presence of a solution of drug. Drug-independent antibodies react with untreated RBCs (no drug added) and cannot be distinguished from warm autoantibodies. Many changes have occurred during the last 30 years, such as which drugs most commonly cause DIIHA, the optimal testing methods for identifying them, and the theories behind the mechanisms by which they react...
2014: Immunohematology
https://www.readbyqxmd.com/read/25247621/drugs-that-have-been-shown-to-cause-drug-induced-immune-hemolytic-anemia-or-positive-direct-antiglobulin-tests-some-interesting-findings-since-2007
#16
REVIEW
George Garratty, Patricia A Arndt
This review updates new findings in drug-induced immune- hemolytic anemia (DIIHA) since the 2007 review in Immunohematology by these authors. Twelve additional drugs have been added to the three tables listing drugs associated with drug-dependent antibodies, drugs associated with drug-independent antibodies, and drugs associated with nonimmunologic protein adsorption. Other updated findings include (1) piperacillin is currently the most commonly encountered cause of DIIHA, (2) new data on blood group specificity of drug-dependent antibodies, (3) drug-dependent antibodies detected in healthy donors, (4) DIIHA associated with transplantation, and(5) DIIHA associated with chemotherapeutic drugs...
2014: Immunohematology
https://www.readbyqxmd.com/read/25247618/how-we-investigate-drug-induced-immune-hemolytic-anemia
#17
REVIEW
Regina M Leger, Patricia A Arndt, George Garratty
Drugs are a rare cause of immune hemolytic anemia, but an investigation for a drug antibody may be warranted if a patient has definitive evidence of immune hemolysis, other more common causes of hemolysis have been excluded, and there is a good temporal relationship between the administration of a drug and the hemolytic event. Drug antibodies are either drug-dependent (require drug to be in the test system) or drug-independent (reactive without drug present in the test). Drug-dependent antibodies are investigated by testing drug-treated red blood cells (RBCs) or by testing RBCs in the presence of a solution of drug...
2014: Immunohematology
https://www.readbyqxmd.com/read/25247617/diagnostic-pitfalls-of-drug-induced-immune-hemolytic-anemia
#18
Abdulgabar Salama, Beate Mayer
Immune hemolytic anemia (IHA) is a rare complication of drug administration. However, its true incidence remains obscure, as there are a number of factors that may lead to misdiagnosis. The clinical and serologic pictures are variable, and there is a great deal of unawareness that certain drugs can cause IHA. Furthermore, serologic results can be easily misinterpreted, resulting in a wrong diagnosis.
2014: Immunohematology
https://www.readbyqxmd.com/read/25189315/drug-induced-immune-haemolytic-anaemia-caused-by-levofloxacin
#19
Shashvat Sukhal, Shweta Gupta
Drug-induced immune haemolytic anaemia (DIIHA) is extremely rare. We herein report a case of life-threatening DIIHA due to levofloxacin. This is the second case reported in the literature. A 51-year-old woman presented with complaints of fatigue after 4-5 days of levofloxacin therapy for a lung infection. At presentation, she was found to have haemolysis with a positive Coombs test and IgG autoantibodies. Levofloxacin was identified as the probable culprit, using the Naranjo adverse drug reaction probability scale...
August 2014: Singapore Medical Journal
https://www.readbyqxmd.com/read/25163809/ceftriaxone-induced-immune-hemolytic-anemia
#20
Gal Neuman, Sabrina Boodhan, Ilana Wurman, Gideon Koren, Ari Bitnun, Melanie Kirby-Allen, Shinya Ito
OBJECTIVES: To describe a case of ceftriaxone-induced immune hemolytic anemia (CIIHA) in a 6 year-old boy with sickle cell disease (SCD) and perform a systematic literature review to delineate the clinical and laboratory features of this condition. DATA SOURCES: EMBASE (1947-January 2014), MEDLINE (1946-January 2014), and databases from the US Food and Drug Administration and Health Canada were searched, using anemia, hemolytic anemia, hemolysis, and ceftriaxone as search terms...
December 2014: Annals of Pharmacotherapy
keyword
keyword
98176
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"